AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials
Breakpoints
The Eradicate Trial for Staff Arias Bacteremia
This is Ceph de Bipril compared to Daptomycin with or without optional as tree name for the treatment of complicated staff, Arias Bacteremia. This was presented by none other than Dr. Tom Holland, who's an associate professor in the division of ID at Duke University Medical Center. Unlike the last trial that got dapedo, it's approval in 2006. And I don't know about y'all, but when I started doing this math, I think I was in junior high when that happened.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode